Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.47% | 131.02 | 0.0% | $2314.17m | |
| BNGO | BioNano Genomics, Inc. | 18.50% | 9.80 | 0.0% | $2016.46m | |
| GILD | Gilead Sciences, Inc. | -0.06% | 66.94 | 1.0% | $649.72m | |
| AMGN | Amgen, Inc. | 0.58% | 253.50 | 1.3% | $564.60m | |
| CRSP | CRISPR Therapeutics AG | 1.83% | 188.49 | 0.6% | $487.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.43% | 537.78 | 2.7% | $478.09m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.19% | 159.73 | 2.0% | $470.59m | |
| NVAX | Novavax, Inc. | 3.74% | 126.98 | 92.9% | $417.43m | |
| ILMN | Illumina, Inc. | 0.34% | 406.25 | 3.5% | $396.72m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.36% | 98.24 | 13.8% | $364.79m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.44% | 237.59 | 1.9% | $361.85m | |
| BIIB | Biogen, Inc. | -0.25% | 269.44 | 1.7% | $321.90m | |
| BNTX | BioNTech SE | 2.86% | 108.44 | 0.0% | $298.33m | |
| EXAS | EXACT Sciences Corp. | 1.30% | 150.00 | 19.6% | $243.95m | |
| PACB | Pacific Biosciences of California, Inc. | 3.06% | 37.42 | 7.4% | $228.17m |
Company Profile
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.